Kintara Therapeutics Announces Fiscal 2024 Third Quarter Financial Results [Yahoo! Finance]
Kintara Therapeutics Announces Fiscal 2024 Third Quarter Financial Results
TuHURA Biosciences to Present Its IFx-2.0 Personalized Cancer Vaccine Clinical Trial Results at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting [Yahoo! Finance]
STOCKHOLDER INVESTIGATION: The M&A Class Action Firm Announces an Investigation of Kintara Biopharma, Inc. - KTRA
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MODN, SCX, KTRA